Maynard Um
-
-
-
-
-
-
-
Bernstein says risk-reward is positively skewed for this pharma stock
-
-
-
-
-
-
-
AstraZeneca (AZN) Q2 earnings preview
-
-
-
-
-
-
-
HSBC Downgrades AstraZeneca (AZN:LN) (AZN) to Hold
-
-
-
-
-
-
-
AstraZeneca and YMCA of the USA form five-year cancer care deal
-
-
-
-
-
-
-
AstraZeneca IMFINZI combo cuts liver cancer progression risk by 30%
-
-
-
-
-
-
-
AstraZeneca's BAXFENDY wins FDA approval for resistant hypertension
-
-
-
-
-
-
-
AstraZeneca (AZN) Tops Q1 EPS by 6c; offers guidance
-
433,310 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

